UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 24.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 486,134 shares of the medical instruments supplier's stock after selling 153,846 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.24% of DENTSPLY SIRONA worth $13,155,000 as of its most recent filing with the SEC.
Several other hedge funds have also modified their holdings of XRAY. Comerica Bank increased its stake in DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier's stock worth $1,413,000 after buying an additional 1,205 shares during the period. Cetera Advisors LLC increased its position in shares of DENTSPLY SIRONA by 18.6% during the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier's stock worth $566,000 after acquiring an additional 2,675 shares during the last quarter. OLD National Bancorp IN lifted its stake in shares of DENTSPLY SIRONA by 84.2% in the second quarter. OLD National Bancorp IN now owns 13,560 shares of the medical instruments supplier's stock worth $338,000 after acquiring an additional 6,198 shares in the last quarter. Securian Asset Management Inc. boosted its holdings in DENTSPLY SIRONA by 33.4% in the second quarter. Securian Asset Management Inc. now owns 16,560 shares of the medical instruments supplier's stock valued at $413,000 after purchasing an additional 4,147 shares during the last quarter. Finally, M&G Plc acquired a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $8,817,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on XRAY. UBS Group cut their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, November 8th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $28.40.
Check Out Our Latest Stock Report on XRAY
DENTSPLY SIRONA Stock Performance
Shares of NASDAQ:XRAY traded down $0.23 during trading on Friday, hitting $19.08. 1,628,151 shares of the company traded hands, compared to its average volume of 3,157,304. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business's fifty day moving average is $21.86 and its 200-day moving average is $24.46. DENTSPLY SIRONA Inc. has a one year low of $17.21 and a one year high of $37.60.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
